Literature DB >> 17171446

Colonic ornithine decarboxylase in inflammatory bowel disease: ileorectal activity gradient, guanosine triphosphate stimulation, and association with epithelial regeneration but not the degree of inflammation and clinical features.

Hubert Allgayer1, Ulla Roisch, Elmar Zehnter, Dieter J Ziegenhagen, Hans P Dienes, Wolfgang Kruis.   

Abstract

The role of colonic mucosal ornithine decarboxylase (ODC) in inflammatory bowel disease (IBD) remains controversial. This study assessed mucosal ODC activity in IBD patients segment by segment with regard to patient characteristics, disease activity/duration, medication, degree of mucosal inflammation, and presence/absence of epithelial regeneration and guanosine triphosphate (GTP) stimulation. Mucosal ODC activity was determined in biopsy specimens from the terminal ileum, cecum/ascending, transverse, and descending colon, and the sigmoid/rectum of 35 patients with IBD (18 with Crohn's disease, 17 with ulcerative colitis) and 29 controls, using the amount of 14CO2 liberated from (carboxyl-14C)ornithine hydrochloride. GTP-stimulatable activity was expressed as the ratio of ODC activity in the presence and absence of GTP (70 micromol/L). Mucosal inflammation was assessed endoscopically/microscopically with previously described criteria. Presence/absence of mucosal regeneration also was determined by predefined criteria. Mucosal ODC-activity did not significantly differ in IBD patients and controls. There was a 4.4-fold activity gradient from the ileum to the rectum. Mucosal ODC activity was significantly higher in areas with epithelial regeneration compared to those without regeneration, and was stimulated by GTP by a factor of 1.42 in Crohn's disease and 1.19 in ulcerative colitis patients compared to controls (p < 0.004). On the other hand, there was no significant association/relationship of mucosal ODC activity with disease activity/duration and the endoscopic/histologic degree of mucosal inflammation. The observation of unchanged mucosal ODC activity in patients with IBD and the absence of a significant relationship with clinical and endoscopic/histologic disease characteristics speaks against a major role of ODC in IBD as a major disease marker. The role of the ileorectal gradient, the enhanced activity in areas with epithelial regeneration, and the GTP-stimulatable form, however, need further investigation with regard to a possible involvement in carcinogenesis in IBD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171446     DOI: 10.1007/s10620-006-9515-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  20 in total

1.  Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis.

Authors:  Salah Amasheh; Christian Barmeyer; Corinna Swanette Koch; Shida Tavalali; Joachim Mankertz; Hans-Jörg Epple; Maren Melanie Gehring; Peter Florian; Anton-Josef Kroesen; Martin Zeitz; Michael Fromm; Jörg-Dieter Schulzke
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

2.  Polyamine metabolism in colonic mucosa from patients with ulcerative colitis.

Authors:  M Obayashi; I Matsui-Yuasa; T Matsumoto; A Kitano; K Kobayashi; S Otani
Journal:  Am J Gastroenterol       Date:  1992-06       Impact factor: 10.864

3.  Properties of ornithine decarboxylase in human colorectal adenocarcinomas.

Authors:  O A Hietala; K Y Yum; J Pilon; K O'Donnell; C P Holroyde; I Kline; G A Reichard; S Litwin; S K Gilmour; T G O'Brien
Journal:  Cancer Res       Date:  1990-04-01       Impact factor: 12.701

4.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.

Authors:  P Gomes; C du Boulay; C L Smith; G Holdstock
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

5.  Effect of short-term topical corticosteroid treatment on mucosal enzyme systems in patients with distal inflammatory bowel disease.

Authors:  C Scheurlen; H Allgayer; M Hardt; W Kruis
Journal:  Hepatogastroenterology       Date:  1998 Sep-Oct

6.  Function and origin of multiple ionic forms of hormone-induced ornithine decarboxylase.

Authors:  J F Richards; A Janzen; T Peng; A Strumpfer
Journal:  Arch Biochem Biophys       Date:  1993-01       Impact factor: 4.013

7.  Activation of mouse epidermal tumor ornithine decarboxylase by GTP: evidence for different catalytic forms of the enzyme.

Authors:  T G O'Brien; O Hietala; K O'Donnell; M Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.

Authors:  N Matsubara; O A Hietala; S K Gilmour; K Y Yum; S Litwin; P Watts
Journal:  Clin Cancer Res       Date:  1995-06       Impact factor: 12.531

9.  Polyamines are necessary for the survival of human small-cell lung carcinoma in culture.

Authors:  G D Luk; G Goodwin; L J Marton; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis.

Authors:  T Fujita; K Sakurai
Journal:  Br J Surg       Date:  1995-06       Impact factor: 6.939

View more
  1 in total

1.  Do biofilms confer a pro-carcinogenic state?

Authors:  Christine M Dejea; Cynthia L Sears
Journal:  Gut Microbes       Date:  2016
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.